Comprehensive Study Notes on Physical Activity Measurement and Pre-Participation Clearance: IPAQ-SF and 2023 PAR-Q+

Physical Activity Assessment and Pre-Participation Screening Overview

• Complementary Clinical and Epidemiological Functions:

  • Health and physical activity evaluation relies on two distinct measurement pathways: quantifying physical activity volume and sedentary patterns, and pre-participation clinical screening to detect contraindications to exercise.

  • Activity Volume Quantification: Captured via standardized surveillance tools like the International Physical Activity Questionnaire (IPAQ) to evaluate overall energy expenditure and population activity patterns.

  • Pre-Participation Screening: Executed via risk stratification instruments like the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) to identify medical risks and establish individualized clearance pathways prior to initiating or progressing an exercise regimen.

International Physical Activity Questionnaire (IPAQ) – Short Form: Instrument Framework

• Instrument Classification and Purpose:

  • Assesses types and intensities of physical activity and sitting time undertaken as part of daily living.

  • Estimates total physical activity volume measured in Metabolic Equivalent of Task minutes per week ($\text{MET-min/week}$) alongside sedentary behavior quantified as total daily sitting time.

• Subscale and Structural Profile:

  • Subscales: None; operates as a single-construct instrument capturing generic physical activity behavior.

  • Total Items: $7$ self-report items using an open-ended recall framework spanning the preceding $7$ days.

  • Stepping Up Strategic Alignment: Health & Wellness theme, targeting the specific outcome that youth are physically healthy.

  • Target Population: Young and middle-aged adults aged $15\text{--}69\,\text{years}$ (validated broadly for youth aged $15\,\text{years}$ and older).

  • Administration Formats: Self-administered paper-and-pencil version, structured oral interview, or telephone administration.

  • Linguistic Availability: English and multiple international language adaptations.

  • Organizational Adoption: Utilized by provincial and community-level funding and research agencies, including the Ontario Trillium Foundation.

• Developmental History and Instrument Suite:

  • Development of an international physical activity measure commenced in Geneva in 1998.

  • Extensive international reliability and validity testing was executed across $12\,\text{countries}$ ($14\,\text{sites}$) throughout 2000.

  • The complete IPAQ assessment suite consists of $4\,\text{questionnaires}$ configured along two structural dimensions:

    • Long Form: Measures $5\,\text{activity domains}$ evaluated independently (work, transportation, domestic/gardening, recreation/leisure, and sitting).

    • Short Form: Measures generic activity across $4\,\text{broad items}$ (vigorous activity, moderate activity, walking, and sitting).

    • Administration Routes: Both long and short versions are validated for telephone interviews and self-administered formats.

  • The primary objective is providing common, standardized metrics for obtaining internationally comparable surveillance data on health-related physical activity.

• Administration Fidelity and Translation Standards:

  • Researchers and practitioners must make no alterations to the wording or sequence of questionnaire items, as modifications invalidate documented psychometric properties.

  • New linguistic and cultural adaptations must adhere strictly to standardized back-translation methodologies curated via the central IPAQ coordinating repository (accessible at www.ipaq.ki.se and https://sites.google.com/site/theipaq/).

  • International prevalence tracking continues through ongoing research initiatives such as the International Physical Activity Prevalence Study.

• Psychometric Properties:

  • Reliability: Test-retest reliability across international sites demonstrated good stability, with high reported internal consistency ($\alpha < 0.80$ reported in foundational documentation; pooled test-retest Spearman correlation coefficients typically $r \approx 0.80$).

  • Validity Profiles: Confirmed across predictive, concurrent, convergent, criterion, and discriminant validity metrics when compared against objective accelerometry and criterion physical activity logs.

IPAQ Short Form: Complete Survey Protocol and Item Architecture

• Participant Instructions and Cognitive Framing:

  • Respondents report all physical activities undertaken during the previous $7\,\text{days}$ across all settings: occupational duties, indoor/outdoor domestic chores, active transportation, recreation, structured exercise, and sports participation.

  • Responses are required regardless of whether the individual identifies as physically active.

  • Inclusion Threshold: Only discrete physical activities sustained for a minimum continuous duration of $10\,\text{minutes}$ qualify for inclusion.

• Vigorous Intensity Domain:

  • Operational Definition: Activities requiring hard physical effort that cause breathing to occur at rates substantially harder than normal.

  • Exemplars: Heavy lifting, digging, aerobics, or fast bicycling.

  • Item 1 (Frequency): "During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling?"

    • Response: Reported as continuous integer ($\text{days per week}$).

    • Skip Logic: Selecting "No vigorous physical activities" routes directly to Item 3.

  • Item 2 (Duration): "How much time did you usually spend doing vigorous physical activities on one of those days?"

    • Response: Quantified in continuous units of $\text{hours per day}$ and $\text{minutes per day}$, or classified as "Don’t know/Not sure".

• Moderate Intensity Domain:

  • Operational Definition: Activities requiring moderate physical effort that induce breathing rates somewhat harder than normal.

  • Exemplars: Carrying light loads, bicycling at a regular cadence, or playing doubles tennis.

  • Exclusion Rule: Walking is explicitly excluded from this category and assessed independently.

  • Item 3 (Frequency): "During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis? Do not include walking."

    • Response: Continuous integer ($\text{days per week}$).

    • Skip Logic: Selecting "No moderate physical activities" routes directly to Item 5.

  • Item 4 (Duration): "How much time did you usually spend doing moderate physical activities on one of those days?"

    • Response: Continuous units of $\text{hours per day}$ and $\text{minutes per day}$, or classified as "Don’t know/Not sure".

• Walking Domain:

  • Operational Definition: All walking accumulated at work, throughout the home, for transportation, and during recreation, sport, exercise, or leisure.

  • Item 5 (Frequency): "During the last 7 days, on how many days did you walk for at least 10 minutes at a time?"

    • Response: Continuous integer ($\text{days per week}$).

    • Skip Logic: Selecting "No walking" routes directly to Item 7.

  • Item 6 (Duration): "How much time did you usually spend walking on one of those days?"

    • Response: Continuous units of $\text{hours per day}$ and $\text{minutes per day}$, or classified as "Don’t know/Not sure".

• Sedentary Behavior (Sitting) Domain:

  • Operational Definition: Time spent sitting during weekdays across the preceding $7\,\text{days}$, encompassing occupational sitting, home sitting, course work, desk-based tasks, visiting friends, reading, or sitting/reclining while viewing television.

  • Item 7 (Duration): "During the last 7 days, how much time did you spend sitting on a week day?"

    • Response: Continuous units of $\text{hours per day}$ and $\text{minutes per day}$, or classified as "Don’t know/Not sure".

Physical Activity Readiness Questionnaire for Everyone (2023 PAR-Q+): Architecture and Scope

• Clinical Screening Philosophy:

  • Physical activity is safe and therapeutic for most individuals, and regular daily participation confers marked health benefits.

  • The PAR-Q+ serves as an evidence-based risk-stratification mechanism determining whether individuals require formal medical evaluation or consultation with a qualified exercise professional (QEP) prior to initiating or expanding activity levels.

• Administrative and Regulatory Requirements:

  • Clearance Period: Approved physical activity clearance remains valid for a maximum duration of $12\,\text{months}$ from the execution date, but immediately becomes invalid if the participant's health or medical status changes.

  • Integrity of Document: Reproduction via photocopying is permitted only if the instrument is reproduced in its entirety without deletions, additions, or modifications to question structure or content.

  • Consent and Legal Minors: Participants below the legal age of consent or those requiring care provider assent must have the document signed by a parent, legal guardian, or designated care provider.

  • Institutional Custody: Community and fitness facilities may maintain completed copies on file while maintaining participant confidentiality in compliance with governing legal statutes.

• General Deferral Criteria (Temporary Contraindications):

  • Acute Illness: Individuals experiencing temporary illnesses such as systemic infection, cold, or fever must delay starting or progressing physical activity until fully recovered.

  • Pregnancy: Individuals who are pregnant must consult their primary physician, obstetric health care provider, or a qualified exercise professional, or complete the specialized electronic pre-participation tool (ePARmed-X+ at www.eparmedx.com) before increasing activity.

  • Health Status Alterations: Any emergent change in health status requires answering the follow-up medical triage sections (Pages 2 and 3) or securing clinical clearance before progressing.

PAR-Q+ General Health Screening Protocol (Page 1)

• Preliminary Screening Architecture:

  • Comprises $7\,\text{dichotomous (YES/NO)}$ general health items designed to identify red-flag signs, symptoms, or diagnoses requiring advanced screening.

• Item-by-Item Specifications:

  • Question 1 (Cardiovascular Health): Has your doctor ever said that you have a heart condition OR high blood pressure?

  • Question 2 (Symptomatic Chest Pain): Do you feel pain in your chest at rest, during your daily activities of living, OR when you do physical activity?

  • Question 3 (Neurological/Equilibrium Dysfunction): Do you lose balance because of dizziness OR have you lost consciousness in the last $12\,\text{months}$?

    • Exception: Participants must answer "NO" if dizziness was exclusively associated with transient hyperventilation/over-breathing (such as during vigorous athletic exertion).

  • Question 4 (Chronic Disease Diagnosis): Have you ever been diagnosed with another chronic medical condition (other than heart disease or high blood pressure)? Requires comprehensive text listing of specific diagnoses.

  • Question 5 (Pharmacotherapy): Are you currently taking prescribed medications for a chronic medical condition? Requires comprehensive text listing of conditions and active pharmacological agents.

  • Question 6 (Musculoskeletal Limitations): Do you currently have (or have had within the past $12\,\text{months}$) a bone, joint, or soft tissue (muscle, ligament, or tendon) problem that could be made worse by becoming more physically active?

    • Exception: Participants answer "NO" if a previous musculoskeletal injury occurred in the past but does not currently limit physical capacity. Conditions must be listed.

  • Question 7 (Clinical Exercise Supervision): Has your doctor ever said that you should only do medically supervised physical activity?

• Negative Screen Disposition Pathway (All 7 Answers "NO"):

  • Immediate Clearance: The participant is cleared for unrestricted physical activity and proceeds directly to signing the Participant Declaration on Page 1, bypassing Pages 2 and 3.

  • Activity Onset Guidelines:

    • Begin slowly and progress physical exertion gradually.

    • Align physical activity routines with established World Health Organization (WHO) Global Physical Activity Guidelines categorized by age cohort.

    • Participation in formal health and fitness appraisals is authorized.

  • Age and Exertion Caveat: Individuals aged $> 45\,\text{years}$ who are not habitually accustomed to regular vigorous or maximal-effort exercise must consult a qualified exercise professional prior to initiating maximal-effort regimens.

• Positive Screen Disposition Pathway (Any Answer "YES"):

  • Immediate clearance is withheld; the respondent is mandated to complete the targeted diagnostic screening sections across Pages 2 and 3.

Chronic Medical Condition Follow-Up Assessment Architecture (Pages 2–3)

• Domain 1: Arthritis, Osteoporosis, or Back Problems:

  • Question 1a: Difficulty controlling condition with medications or physician-prescribed therapies (answer "NO" if not taking medical therapies).

  • Question 1b: Presence of joint problems causing active pain, a recent fracture, a fragility fracture secondary to osteoporosis or cancer, displaced vertebra (spondylolisthesis), or spondylolysis/pars defect (structural crack in the posterior bony ring of the vertebra).

  • Question 1c: Administration of regular corticosteroid injections or oral steroid tablets sustained continuously for $> 3\,\text{months}$.

• Domain 2: Cancer:

  • Question 2a: Specific oncological diagnoses involving lung/bronchogenic carcinoma, multiple myeloma (malignancy of plasma cells), or head and neck cancers.

  • Question 2b: Active engagement in oncological therapies (including systemic chemotherapy or radiotherapy).

• Domain 3: Cardiovascular Conditions:

  • Encompasses coronary artery disease (CAD), heart failure, and diagnosed cardiac dysrhythmias.

  • Question 3a: Difficulty controlling cardiovascular condition with medications or prescribed therapies.

  • Question 3b: Diagnosed irregular heartbeat requiring active medical management (such as atrial fibrillation or recurrent premature ventricular contractions [PVCs]).

  • Question 3c: Clinical diagnosis of chronic heart failure.

  • Question 3d: Diagnosed coronary artery (cardiovascular) disease combined with physical inactivity (failure to participate in regular physical activity over the preceding $2\,\text{months}$).

• Domain 4: Hypertension:

  • Question 4a: Inability to achieve clinical control with antihypertensive pharmacotherapy or physician-prescribed interventions.

  • Question 4b: Resting hemodynamic profile displaying a resting systolic blood pressure $\ge 160\,\text{mmHg}$ or resting diastolic blood pressure $\ge 90\,\text{mmHg}$ (with or without medication).

    • Classification Rule: Participants who do not know their resting blood pressure must default to answering "YES".

• Domain 5: Metabolic Conditions:

  • Encompasses Type 1 Diabetes, Type 2 Diabetes, and Pre-Diabetes.

  • Question 5a: Inability to reliably stabilize blood glucose through nutritional protocols, insulin, oral agents, or prescribed therapies.

  • Question 5b: Frequent symptoms of post-exercise or resting hypoglycemia (manifesting as shakiness, nervousness, pathological irritability, diaphoresis, light-headedness, confusion, dysarthria/speech difficulty, weakness, or somnolence).

  • Question 5c: Presence of secondary microvascular or macrovascular diabetes complications (coronary/peripheral vascular disease, retinopathy, nephropathy, or peripheral neuropathy characterized by loss of sensation in toes and feet).

  • Question 5d: Co-occurrence of secondary metabolic conditions (active gestational diabetes, chronic kidney disease, or hepatic dysfunction).

  • Question 5e: Current intention to undertake exercise that represents an unusually high or unaccustomed vigorous intensity.

• Domain 6: Mental Health and Neurodevelopmental Conditions:

  • Encompasses Alzheimer's disease, dementia, major depressive disorder, generalized anxiety, eating disorders, psychotic disorders, intellectual disability, and Down syndrome.

  • Question 6a: Inadequate clinical stabilization via medications or prescribed therapeutic regimens.

  • Question 6b: Dual presentation of Down syndrome accompanied by spinal/cervical back problems producing neuromuscular compromise.

• Domain 7: Respiratory Disease:

  • Encompasses Chronic Obstructive Pulmonary Disease (COPD), asthma, and pulmonary hypertension.

  • Question 7a: Poor symptomatic control with inhaler therapies, oral medications, or prescribed management.

  • Question 7b: Documented arterial hypoxemia at rest or during physical exertion, or medical requirement for supplemental oxygen therapy.

  • Question 7c: For asthmatic individuals: active clinical instability marked by chest tightness, audible wheezing, labored respiration, persistent coughing ($> 2\,\text{days/week}$), or acute rescue inhaler utilization exceeding $> 2\,\text{times/week}$.

  • Question 7d: Diagnosed pulmonary arterial hypertension (elevated vascular resistance within pulmonary circulation).

• Domain 8: Spinal Cord Injury:

  • Encompasses tetraplegia and paraplegia.

  • Question 8a: Instability or poor therapeutic control under current clinical management.

  • Question 8b: Severe resting hypotension precipitating dizziness, light-headedness, or syncope.

  • Question 8c: Diagnosed episodes of Autonomic Dysreflexia (acute, life-threatening paroxysmal hypertension triggered by noxious stimuli below the lesion level).

• Domain 9: Cerebrovascular Compromise:

  • Encompasses Transient Ischemic Attack (TIA), ischemic stroke, and hemorrhagic cerebrovascular events.

  • Question 9a: Difficulty stabilizing cerebrovascular condition with current therapies.

  • Question 9b: Persistent functional impairment affecting gait or gross motor mobility.

  • Question 9c: Acute cerebrovascular event or emergent neuromuscular impairment sustained within the preceding $6\,\text{months}$.

• Domain 10: Other Medical Conditions and Multimorbidity:

  • Question 10a: Recent loss of consciousness, syncopal episode, or blackout secondary to head trauma within the past $12\,\text{months}$, or clinical diagnosis of cerebral concussion within the past $12\,\text{months}$.

  • Question 10b: Unlisted chronic medical conditions (such as epilepsy, non-stroke neurodegenerative pathology, or advanced renal dysfunction).

  • Question 10c: Documented medical multimorbidity (living concurrently with $2\,\text{or more}$ chronic medical conditions).

  • Documentation Mandate: Specific chronic conditions and all accompanying pharmacological regimens must be detailed in the written text fields provided.

Clinical Decision Pathways, Recommendations, and Declarations (Page 4)

• Disposition for Negative Follow-Up Screens (All Follow-Up Items "NO"):

  • Activity Clearance: The individual is cleared to begin physical activity and signs the Participant Declaration on Page 4.

  • Professional Consultation: Consultation with a qualified exercise professional (QEP) is recommended to formulate an individualized, safe, and effective training prescription.

  • Initial Exercise Dosing Parameters:

    • Volume and Duration: Initial sessions should span $20\text{--}60\,\text{minutes}$ per session.

    • Intensity: Low-to-moderate intensity exertion.

    • Frequency: $3\text{--}5\,\text{days per week}$.

    • Modality: Combined aerobic conditioning and progressive muscle-strengthening exercise.

  • Progression Target: Systematic advancement toward accumulating $\ge 150\,\text{minutes/week}$ of moderate-intensity physical activity.

  • Advanced Age Consideration: Individuals aged $> 45\,\text{years}$ not habituated to vigorous-to-maximal exercise must obtain guidance from a QEP prior to performing high-intensity exercise.

• Disposition for Positive Follow-Up Screens (One or More Items "YES"):

  • Clearance Withheld: Direct, unsupervised clearance is denied.

  • Required Secondary Action:

    • Complete advanced algorithmic triage via the online Electronic Physical Activity Readiness Medical Examination (ePARmed-X+ at www.eparmedx.com).

    • Consult directly with a qualified exercise professional to complete the ePARmed-X+ review and obtain clinical recommendations.

    • Obtain formal physician clearance prior to participating in physical activity programs or exercise fitness appraisals.

• Legal Protections and Participant Declaration Structure:

  • Liability Disclaimer: The PAR-Q+ Collaboration, authorial steering committee, and partner organizations assume no liability for adverse events, injury, or mortality resulting from physical activity participation or the administrative use of the PAR-Q+ or ePARmed-X+ tools.

  • Execution Fields:

    • Participant printed name and signature.

    • Signature of parent, legal guardian, or designated care provider (for minors or dependent adults).

    • Date of execution (initiating the $12\text{-month}$ validity period).

    • Formal witness signature.

Empirical Foundations, Development Methodology, and Reference Compendium

• Developmental Framework of PAR-Q+:

  • Created using the evidence-based Appraisal of Guidelines for Research and Evaluation (AGREE) process.

  • Developed by the international PAR-Q+ Collaboration steering committee chaired by Dr. Darren E. R. Warburton, alongside Dr. Norman Gledhill, Dr. Veronica Jamnik, and Dr. Donald C. McKenzie.

  • Supported through institutional funding from the Public Health Agency of Canada and the British Columbia (BC) Ministry of Health Services.

• Foundational PAR-Q+ Literature:

  • Warburton DER, Jamnik VK, Bredin SSD, and Gledhill N on behalf of the PAR-Q+ Collaboration. (2011). The Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and Electronic Physical Activity Readiness Medical Examination (ePARmed-X+). Health & Fitness Journal of Canada, 4(2):3–23.

  • Jamnik VK, Warburton DER, Makarski J, McKenzie DC, Shephard RJ, Stone J, and Gledhill N. (2011). Enhancing the effectiveness of clearance for physical activity participation; background and overall process. Applied Physiology, Nutrition, and Metabolism (APNM), 36(S1):S3–S13.

  • Warburton DER, Gledhill N, Jamnik VK, Bredin SSD, McKenzie DC, Stone J, Charlesworth S, and Shephard RJ. (2011). Evidence-based risk assessment and recommendations for physical activity clearance; Consensus Document. Applied Physiology, Nutrition, and Metabolism (APNM), 36(S1):S266–S298.

  • Chisholm DM, Collis ML, Kulak LL, Davenport W, and Gruber N. (1975). Physical activity readiness. British Columbia Medical Journal, 17:375–378.

  • Thomas S, Reading J, and Shephard RJ. (1992). Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Canadian Journal of Sport Science, 17(4):338–345.

• Foundational IPAQ Literature:

  • Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71(2):s114–s120.

  • Craig, C.L., Marshall, A., Sjostrom, M., Bauman, A., Booth, M., Ainsworth, B., et al. (2003). International Physical Activity Questionnaire: 12-country reliability and validity. Medicine & Science in Sports & Exercise, 35:1381–1395.

  • van Poppel, M.N.M., Chinapaw, M.J.M., Mokkink, L.B., van Mechelen, W., Terwee, C.B. (2010). Physical activity questionnaires for adults: A systematic review of measurement properties. Sports Medicine, 40:565–600.

  • Lee, P.H., Macfarlane, D.J., Lam, T.H., Stewart, S.M. (2011). Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review. International Journal of Behavioral Nutrition and Physical Activity, 8:115.